nodes	percent_of_prediction	percent_of_DWPC	metapath
Rivastigmine—CYP2D6—Progesterone—uterine cancer	0.114	0.296	CbGbCtD
Rivastigmine—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.109	0.284	CbGbCtD
Rivastigmine—CYP3A4—Progesterone—uterine cancer	0.0723	0.188	CbGbCtD
Rivastigmine—CYP2D6—Doxorubicin—uterine cancer	0.0347	0.0903	CbGbCtD
Rivastigmine—CYP3A4—Etoposide—uterine cancer	0.0324	0.0842	CbGbCtD
Rivastigmine—CYP3A4—Doxorubicin—uterine cancer	0.0221	0.0574	CbGbCtD
Rivastigmine—Nasopharyngitis—Doxorubicin—uterine cancer	0.000249	0.000405	CcSEcCtD
Rivastigmine—Hypotension—Etoposide—uterine cancer	0.000247	0.000401	CcSEcCtD
Rivastigmine—Gastritis—Doxorubicin—uterine cancer	0.000247	0.000401	CcSEcCtD
Rivastigmine—Muscular weakness—Doxorubicin—uterine cancer	0.000246	0.000399	CcSEcCtD
Rivastigmine—Dysuria—Epirubicin—uterine cancer	0.000243	0.000395	CcSEcCtD
Rivastigmine—Upper respiratory tract infection—Epirubicin—uterine cancer	0.000242	0.000393	CcSEcCtD
Rivastigmine—Dysphagia—Doxorubicin—uterine cancer	0.000241	0.000391	CcSEcCtD
Rivastigmine—Pollakiuria—Epirubicin—uterine cancer	0.00024	0.000391	CcSEcCtD
Rivastigmine—Photosensitivity reaction—Epirubicin—uterine cancer	0.000238	0.000386	CcSEcCtD
Rivastigmine—Paraesthesia—Etoposide—uterine cancer	0.000237	0.000385	CcSEcCtD
Rivastigmine—Weight increased—Epirubicin—uterine cancer	0.000237	0.000385	CcSEcCtD
Rivastigmine—Pancreatitis—Doxorubicin—uterine cancer	0.000236	0.000384	CcSEcCtD
Rivastigmine—Weight decreased—Epirubicin—uterine cancer	0.000235	0.000383	CcSEcCtD
Rivastigmine—Dyspnoea—Etoposide—uterine cancer	0.000235	0.000382	CcSEcCtD
Rivastigmine—Hyperglycaemia—Epirubicin—uterine cancer	0.000235	0.000381	CcSEcCtD
Rivastigmine—Somnolence—Etoposide—uterine cancer	0.000235	0.000381	CcSEcCtD
Rivastigmine—Angina pectoris—Doxorubicin—uterine cancer	0.000235	0.000381	CcSEcCtD
Rivastigmine—Pneumonia—Epirubicin—uterine cancer	0.000233	0.000379	CcSEcCtD
Rivastigmine—Drowsiness—Epirubicin—uterine cancer	0.000232	0.000377	CcSEcCtD
Rivastigmine—Infestation NOS—Epirubicin—uterine cancer	0.000232	0.000377	CcSEcCtD
Rivastigmine—Infestation—Epirubicin—uterine cancer	0.000232	0.000377	CcSEcCtD
Rivastigmine—Vomiting—Dactinomycin—uterine cancer	0.000232	0.000377	CcSEcCtD
Rivastigmine—Bronchitis—Doxorubicin—uterine cancer	0.000232	0.000376	CcSEcCtD
Rivastigmine—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.00023	0.000374	CcSEcCtD
Rivastigmine—Rash—Dactinomycin—uterine cancer	0.00023	0.000374	CcSEcCtD
Rivastigmine—Decreased appetite—Etoposide—uterine cancer	0.00023	0.000373	CcSEcCtD
Rivastigmine—Renal failure—Epirubicin—uterine cancer	0.000228	0.000371	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Etoposide—uterine cancer	0.000228	0.00037	CcSEcCtD
Rivastigmine—Fatigue—Etoposide—uterine cancer	0.000228	0.00037	CcSEcCtD
Rivastigmine—Neuropathy peripheral—Epirubicin—uterine cancer	0.000228	0.00037	CcSEcCtD
Rivastigmine—Pain—Etoposide—uterine cancer	0.000226	0.000367	CcSEcCtD
Rivastigmine—Constipation—Etoposide—uterine cancer	0.000226	0.000367	CcSEcCtD
Rivastigmine—Conjunctivitis—Epirubicin—uterine cancer	0.000226	0.000367	CcSEcCtD
Rivastigmine—Urinary tract infection—Epirubicin—uterine cancer	0.000226	0.000367	CcSEcCtD
Rivastigmine—Dysuria—Doxorubicin—uterine cancer	0.000225	0.000366	CcSEcCtD
Rivastigmine—Upper respiratory tract infection—Doxorubicin—uterine cancer	0.000224	0.000364	CcSEcCtD
Rivastigmine—Sweating—Epirubicin—uterine cancer	0.000223	0.000361	CcSEcCtD
Rivastigmine—Pollakiuria—Doxorubicin—uterine cancer	0.000222	0.000361	CcSEcCtD
Rivastigmine—Haematuria—Epirubicin—uterine cancer	0.000221	0.00036	CcSEcCtD
Rivastigmine—Photosensitivity reaction—Doxorubicin—uterine cancer	0.00022	0.000357	CcSEcCtD
Rivastigmine—Hepatobiliary disease—Epirubicin—uterine cancer	0.00022	0.000357	CcSEcCtD
Rivastigmine—Weight increased—Doxorubicin—uterine cancer	0.000219	0.000356	CcSEcCtD
Rivastigmine—Epistaxis—Epirubicin—uterine cancer	0.000219	0.000356	CcSEcCtD
Rivastigmine—Weight decreased—Doxorubicin—uterine cancer	0.000218	0.000354	CcSEcCtD
Rivastigmine—Sinusitis—Epirubicin—uterine cancer	0.000218	0.000354	CcSEcCtD
Rivastigmine—Feeling abnormal—Etoposide—uterine cancer	0.000218	0.000354	CcSEcCtD
Rivastigmine—Hyperglycaemia—Doxorubicin—uterine cancer	0.000217	0.000353	CcSEcCtD
Rivastigmine—Nausea—Dactinomycin—uterine cancer	0.000217	0.000352	CcSEcCtD
Rivastigmine—Pneumonia—Doxorubicin—uterine cancer	0.000216	0.000351	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Etoposide—uterine cancer	0.000216	0.000351	CcSEcCtD
Rivastigmine—Infestation NOS—Doxorubicin—uterine cancer	0.000215	0.000349	CcSEcCtD
Rivastigmine—Drowsiness—Doxorubicin—uterine cancer	0.000215	0.000349	CcSEcCtD
Rivastigmine—Infestation—Doxorubicin—uterine cancer	0.000215	0.000349	CcSEcCtD
Rivastigmine—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.000213	0.000346	CcSEcCtD
Rivastigmine—Bradycardia—Epirubicin—uterine cancer	0.000212	0.000345	CcSEcCtD
Rivastigmine—Renal failure—Doxorubicin—uterine cancer	0.000211	0.000343	CcSEcCtD
Rivastigmine—Neuropathy peripheral—Doxorubicin—uterine cancer	0.000211	0.000342	CcSEcCtD
Rivastigmine—Urticaria—Etoposide—uterine cancer	0.00021	0.000341	CcSEcCtD
Rivastigmine—Haemoglobin—Epirubicin—uterine cancer	0.000209	0.00034	CcSEcCtD
Rivastigmine—Rhinitis—Epirubicin—uterine cancer	0.000209	0.000339	CcSEcCtD
Rivastigmine—Abdominal pain—Etoposide—uterine cancer	0.000209	0.000339	CcSEcCtD
Rivastigmine—Body temperature increased—Etoposide—uterine cancer	0.000209	0.000339	CcSEcCtD
Rivastigmine—Conjunctivitis—Doxorubicin—uterine cancer	0.000209	0.000339	CcSEcCtD
Rivastigmine—Urinary tract infection—Doxorubicin—uterine cancer	0.000209	0.000339	CcSEcCtD
Rivastigmine—Haemorrhage—Epirubicin—uterine cancer	0.000208	0.000338	CcSEcCtD
Rivastigmine—Hepatitis—Epirubicin—uterine cancer	0.000208	0.000338	CcSEcCtD
Rivastigmine—Hypoaesthesia—Epirubicin—uterine cancer	0.000207	0.000337	CcSEcCtD
Rivastigmine—Pharyngitis—Epirubicin—uterine cancer	0.000207	0.000336	CcSEcCtD
Rivastigmine—Sweating—Doxorubicin—uterine cancer	0.000206	0.000334	CcSEcCtD
Rivastigmine—Urinary tract disorder—Epirubicin—uterine cancer	0.000206	0.000334	CcSEcCtD
Rivastigmine—Oedema peripheral—Epirubicin—uterine cancer	0.000205	0.000333	CcSEcCtD
Rivastigmine—Haematuria—Doxorubicin—uterine cancer	0.000205	0.000333	CcSEcCtD
Rivastigmine—Connective tissue disorder—Epirubicin—uterine cancer	0.000205	0.000333	CcSEcCtD
Rivastigmine—Urethral disorder—Epirubicin—uterine cancer	0.000204	0.000332	CcSEcCtD
Rivastigmine—Hepatobiliary disease—Doxorubicin—uterine cancer	0.000203	0.00033	CcSEcCtD
Rivastigmine—Epistaxis—Doxorubicin—uterine cancer	0.000203	0.000329	CcSEcCtD
Rivastigmine—Sinusitis—Doxorubicin—uterine cancer	0.000201	0.000327	CcSEcCtD
Rivastigmine—Visual impairment—Epirubicin—uterine cancer	0.000201	0.000326	CcSEcCtD
Rivastigmine—Erythema multiforme—Epirubicin—uterine cancer	0.000197	0.00032	CcSEcCtD
Rivastigmine—Bradycardia—Doxorubicin—uterine cancer	0.000196	0.000319	CcSEcCtD
Rivastigmine—Eye disorder—Epirubicin—uterine cancer	0.000195	0.000316	CcSEcCtD
Rivastigmine—Hypersensitivity—Etoposide—uterine cancer	0.000195	0.000316	CcSEcCtD
Rivastigmine—Tinnitus—Epirubicin—uterine cancer	0.000194	0.000316	CcSEcCtD
Rivastigmine—Haemoglobin—Doxorubicin—uterine cancer	0.000194	0.000315	CcSEcCtD
Rivastigmine—Cardiac disorder—Epirubicin—uterine cancer	0.000193	0.000314	CcSEcCtD
Rivastigmine—Flushing—Epirubicin—uterine cancer	0.000193	0.000314	CcSEcCtD
Rivastigmine—Rhinitis—Doxorubicin—uterine cancer	0.000193	0.000314	CcSEcCtD
Rivastigmine—Hepatitis—Doxorubicin—uterine cancer	0.000193	0.000313	CcSEcCtD
Rivastigmine—Haemorrhage—Doxorubicin—uterine cancer	0.000193	0.000313	CcSEcCtD
Rivastigmine—Hypoaesthesia—Doxorubicin—uterine cancer	0.000192	0.000312	CcSEcCtD
Rivastigmine—Pharyngitis—Doxorubicin—uterine cancer	0.000191	0.000311	CcSEcCtD
Rivastigmine—Urinary tract disorder—Doxorubicin—uterine cancer	0.00019	0.000309	CcSEcCtD
Rivastigmine—Oedema peripheral—Doxorubicin—uterine cancer	0.00019	0.000309	CcSEcCtD
Rivastigmine—Asthenia—Etoposide—uterine cancer	0.000189	0.000308	CcSEcCtD
Rivastigmine—Connective tissue disorder—Doxorubicin—uterine cancer	0.000189	0.000308	CcSEcCtD
Rivastigmine—Angiopathy—Epirubicin—uterine cancer	0.000189	0.000307	CcSEcCtD
Rivastigmine—Urethral disorder—Doxorubicin—uterine cancer	0.000189	0.000307	CcSEcCtD
Rivastigmine—Mediastinal disorder—Epirubicin—uterine cancer	0.000188	0.000305	CcSEcCtD
Rivastigmine—Chills—Epirubicin—uterine cancer	0.000187	0.000304	CcSEcCtD
Rivastigmine—Pruritus—Etoposide—uterine cancer	0.000187	0.000304	CcSEcCtD
Rivastigmine—Arrhythmia—Epirubicin—uterine cancer	0.000186	0.000302	CcSEcCtD
Rivastigmine—Visual impairment—Doxorubicin—uterine cancer	0.000186	0.000302	CcSEcCtD
Rivastigmine—Alopecia—Epirubicin—uterine cancer	0.000184	0.000299	CcSEcCtD
Rivastigmine—Mental disorder—Epirubicin—uterine cancer	0.000183	0.000297	CcSEcCtD
Rivastigmine—Erythema multiforme—Doxorubicin—uterine cancer	0.000182	0.000296	CcSEcCtD
Rivastigmine—Erythema—Epirubicin—uterine cancer	0.000181	0.000295	CcSEcCtD
Rivastigmine—Malnutrition—Epirubicin—uterine cancer	0.000181	0.000295	CcSEcCtD
Rivastigmine—Diarrhoea—Etoposide—uterine cancer	0.000181	0.000294	CcSEcCtD
Rivastigmine—Eye disorder—Doxorubicin—uterine cancer	0.00018	0.000293	CcSEcCtD
Rivastigmine—Tinnitus—Doxorubicin—uterine cancer	0.00018	0.000292	CcSEcCtD
Rivastigmine—Flushing—Doxorubicin—uterine cancer	0.000179	0.000291	CcSEcCtD
Rivastigmine—Cardiac disorder—Doxorubicin—uterine cancer	0.000179	0.000291	CcSEcCtD
Rivastigmine—Flatulence—Epirubicin—uterine cancer	0.000179	0.00029	CcSEcCtD
Rivastigmine—Tension—Epirubicin—uterine cancer	0.000178	0.000289	CcSEcCtD
Rivastigmine—Dysgeusia—Epirubicin—uterine cancer	0.000178	0.000289	CcSEcCtD
Rivastigmine—Nervousness—Epirubicin—uterine cancer	0.000176	0.000286	CcSEcCtD
Rivastigmine—Back pain—Epirubicin—uterine cancer	0.000175	0.000285	CcSEcCtD
Rivastigmine—Angiopathy—Doxorubicin—uterine cancer	0.000175	0.000284	CcSEcCtD
Rivastigmine—Dizziness—Etoposide—uterine cancer	0.000175	0.000284	CcSEcCtD
Rivastigmine—Muscle spasms—Epirubicin—uterine cancer	0.000174	0.000283	CcSEcCtD
Rivastigmine—Mediastinal disorder—Doxorubicin—uterine cancer	0.000174	0.000282	CcSEcCtD
Rivastigmine—Chills—Doxorubicin—uterine cancer	0.000173	0.000281	CcSEcCtD
Rivastigmine—Arrhythmia—Doxorubicin—uterine cancer	0.000172	0.00028	CcSEcCtD
Rivastigmine—Vision blurred—Epirubicin—uterine cancer	0.000171	0.000278	CcSEcCtD
Rivastigmine—Alopecia—Doxorubicin—uterine cancer	0.00017	0.000277	CcSEcCtD
Rivastigmine—Mental disorder—Doxorubicin—uterine cancer	0.000169	0.000274	CcSEcCtD
Rivastigmine—Ill-defined disorder—Epirubicin—uterine cancer	0.000168	0.000273	CcSEcCtD
Rivastigmine—Vomiting—Etoposide—uterine cancer	0.000168	0.000273	CcSEcCtD
Rivastigmine—Erythema—Doxorubicin—uterine cancer	0.000168	0.000273	CcSEcCtD
Rivastigmine—Malnutrition—Doxorubicin—uterine cancer	0.000168	0.000273	CcSEcCtD
Rivastigmine—Anaemia—Epirubicin—uterine cancer	0.000168	0.000272	CcSEcCtD
Rivastigmine—Agitation—Epirubicin—uterine cancer	0.000167	0.000271	CcSEcCtD
Rivastigmine—Rash—Etoposide—uterine cancer	0.000167	0.00027	CcSEcCtD
Rivastigmine—Dermatitis—Etoposide—uterine cancer	0.000166	0.00027	CcSEcCtD
Rivastigmine—Headache—Etoposide—uterine cancer	0.000165	0.000269	CcSEcCtD
Rivastigmine—Flatulence—Doxorubicin—uterine cancer	0.000165	0.000269	CcSEcCtD
Rivastigmine—Tension—Doxorubicin—uterine cancer	0.000165	0.000268	CcSEcCtD
Rivastigmine—Dysgeusia—Doxorubicin—uterine cancer	0.000164	0.000267	CcSEcCtD
Rivastigmine—Malaise—Epirubicin—uterine cancer	0.000164	0.000266	CcSEcCtD
Rivastigmine—Nervousness—Doxorubicin—uterine cancer	0.000163	0.000265	CcSEcCtD
Rivastigmine—Vertigo—Epirubicin—uterine cancer	0.000163	0.000265	CcSEcCtD
Rivastigmine—Syncope—Epirubicin—uterine cancer	0.000163	0.000264	CcSEcCtD
Rivastigmine—Back pain—Doxorubicin—uterine cancer	0.000162	0.000264	CcSEcCtD
Rivastigmine—Muscle spasms—Doxorubicin—uterine cancer	0.000161	0.000262	CcSEcCtD
Rivastigmine—Palpitations—Epirubicin—uterine cancer	0.00016	0.00026	CcSEcCtD
Rivastigmine—Loss of consciousness—Epirubicin—uterine cancer	0.000159	0.000259	CcSEcCtD
Rivastigmine—Cough—Epirubicin—uterine cancer	0.000158	0.000257	CcSEcCtD
Rivastigmine—Vision blurred—Doxorubicin—uterine cancer	0.000158	0.000257	CcSEcCtD
Rivastigmine—Convulsion—Epirubicin—uterine cancer	0.000157	0.000255	CcSEcCtD
Rivastigmine—Nausea—Etoposide—uterine cancer	0.000157	0.000255	CcSEcCtD
Rivastigmine—Hypertension—Epirubicin—uterine cancer	0.000157	0.000254	CcSEcCtD
Rivastigmine—Ill-defined disorder—Doxorubicin—uterine cancer	0.000156	0.000253	CcSEcCtD
Rivastigmine—Anaemia—Doxorubicin—uterine cancer	0.000155	0.000252	CcSEcCtD
Rivastigmine—Myalgia—Epirubicin—uterine cancer	0.000154	0.000251	CcSEcCtD
Rivastigmine—Chest pain—Epirubicin—uterine cancer	0.000154	0.000251	CcSEcCtD
Rivastigmine—Arthralgia—Epirubicin—uterine cancer	0.000154	0.000251	CcSEcCtD
Rivastigmine—Agitation—Doxorubicin—uterine cancer	0.000154	0.000251	CcSEcCtD
Rivastigmine—Anxiety—Epirubicin—uterine cancer	0.000154	0.00025	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000153	0.000249	CcSEcCtD
Rivastigmine—Discomfort—Epirubicin—uterine cancer	0.000153	0.000248	CcSEcCtD
Rivastigmine—Malaise—Doxorubicin—uterine cancer	0.000151	0.000246	CcSEcCtD
Rivastigmine—Dry mouth—Epirubicin—uterine cancer	0.000151	0.000245	CcSEcCtD
Rivastigmine—Vertigo—Doxorubicin—uterine cancer	0.000151	0.000245	CcSEcCtD
Rivastigmine—Syncope—Doxorubicin—uterine cancer	0.00015	0.000244	CcSEcCtD
Rivastigmine—Confusional state—Epirubicin—uterine cancer	0.000149	0.000242	CcSEcCtD
Rivastigmine—Palpitations—Doxorubicin—uterine cancer	0.000148	0.000241	CcSEcCtD
Rivastigmine—Oedema—Epirubicin—uterine cancer	0.000148	0.00024	CcSEcCtD
Rivastigmine—Loss of consciousness—Doxorubicin—uterine cancer	0.000147	0.00024	CcSEcCtD
Rivastigmine—Infection—Epirubicin—uterine cancer	0.000147	0.000239	CcSEcCtD
Rivastigmine—Cough—Doxorubicin—uterine cancer	0.000146	0.000238	CcSEcCtD
Rivastigmine—Shock—Epirubicin—uterine cancer	0.000146	0.000237	CcSEcCtD
Rivastigmine—Convulsion—Doxorubicin—uterine cancer	0.000145	0.000236	CcSEcCtD
Rivastigmine—Nervous system disorder—Epirubicin—uterine cancer	0.000145	0.000236	CcSEcCtD
Rivastigmine—Thrombocytopenia—Epirubicin—uterine cancer	0.000145	0.000235	CcSEcCtD
Rivastigmine—Hypertension—Doxorubicin—uterine cancer	0.000145	0.000235	CcSEcCtD
Rivastigmine—Tachycardia—Epirubicin—uterine cancer	0.000144	0.000235	CcSEcCtD
Rivastigmine—Skin disorder—Epirubicin—uterine cancer	0.000144	0.000234	CcSEcCtD
Rivastigmine—Hyperhidrosis—Epirubicin—uterine cancer	0.000143	0.000232	CcSEcCtD
Rivastigmine—Arthralgia—Doxorubicin—uterine cancer	0.000143	0.000232	CcSEcCtD
Rivastigmine—Myalgia—Doxorubicin—uterine cancer	0.000143	0.000232	CcSEcCtD
Rivastigmine—Chest pain—Doxorubicin—uterine cancer	0.000143	0.000232	CcSEcCtD
Rivastigmine—Anxiety—Doxorubicin—uterine cancer	0.000142	0.000231	CcSEcCtD
Rivastigmine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000142	0.000231	CcSEcCtD
Rivastigmine—Discomfort—Doxorubicin—uterine cancer	0.000141	0.000229	CcSEcCtD
Rivastigmine—Anorexia—Epirubicin—uterine cancer	0.000141	0.000229	CcSEcCtD
Rivastigmine—Dry mouth—Doxorubicin—uterine cancer	0.00014	0.000227	CcSEcCtD
Rivastigmine—Hypotension—Epirubicin—uterine cancer	0.000138	0.000225	CcSEcCtD
Rivastigmine—Confusional state—Doxorubicin—uterine cancer	0.000138	0.000224	CcSEcCtD
Rivastigmine—Oedema—Doxorubicin—uterine cancer	0.000137	0.000223	CcSEcCtD
Rivastigmine—Infection—Doxorubicin—uterine cancer	0.000136	0.000221	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000135	0.000219	CcSEcCtD
Rivastigmine—Shock—Doxorubicin—uterine cancer	0.000135	0.000219	CcSEcCtD
Rivastigmine—Nervous system disorder—Doxorubicin—uterine cancer	0.000134	0.000218	CcSEcCtD
Rivastigmine—Thrombocytopenia—Doxorubicin—uterine cancer	0.000134	0.000218	CcSEcCtD
Rivastigmine—Insomnia—Epirubicin—uterine cancer	0.000134	0.000218	CcSEcCtD
Rivastigmine—Tachycardia—Doxorubicin—uterine cancer	0.000134	0.000217	CcSEcCtD
Rivastigmine—Skin disorder—Doxorubicin—uterine cancer	0.000133	0.000216	CcSEcCtD
Rivastigmine—Paraesthesia—Epirubicin—uterine cancer	0.000133	0.000216	CcSEcCtD
Rivastigmine—Hyperhidrosis—Doxorubicin—uterine cancer	0.000132	0.000215	CcSEcCtD
Rivastigmine—Dyspnoea—Epirubicin—uterine cancer	0.000132	0.000214	CcSEcCtD
Rivastigmine—Somnolence—Epirubicin—uterine cancer	0.000132	0.000214	CcSEcCtD
Rivastigmine—Anorexia—Doxorubicin—uterine cancer	0.000131	0.000212	CcSEcCtD
Rivastigmine—Dyspepsia—Epirubicin—uterine cancer	0.00013	0.000212	CcSEcCtD
Rivastigmine—Decreased appetite—Epirubicin—uterine cancer	0.000129	0.000209	CcSEcCtD
Rivastigmine—Hypotension—Doxorubicin—uterine cancer	0.000128	0.000208	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000128	0.000208	CcSEcCtD
Rivastigmine—Fatigue—Epirubicin—uterine cancer	0.000128	0.000207	CcSEcCtD
Rivastigmine—Pain—Epirubicin—uterine cancer	0.000127	0.000206	CcSEcCtD
Rivastigmine—Constipation—Epirubicin—uterine cancer	0.000127	0.000206	CcSEcCtD
Rivastigmine—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.000125	0.000203	CcSEcCtD
Rivastigmine—Insomnia—Doxorubicin—uterine cancer	0.000124	0.000201	CcSEcCtD
Rivastigmine—Paraesthesia—Doxorubicin—uterine cancer	0.000123	0.0002	CcSEcCtD
Rivastigmine—Dyspnoea—Doxorubicin—uterine cancer	0.000122	0.000198	CcSEcCtD
Rivastigmine—Feeling abnormal—Epirubicin—uterine cancer	0.000122	0.000198	CcSEcCtD
Rivastigmine—Somnolence—Doxorubicin—uterine cancer	0.000122	0.000198	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Epirubicin—uterine cancer	0.000121	0.000197	CcSEcCtD
Rivastigmine—Dyspepsia—Doxorubicin—uterine cancer	0.000121	0.000196	CcSEcCtD
Rivastigmine—Decreased appetite—Doxorubicin—uterine cancer	0.000119	0.000193	CcSEcCtD
Rivastigmine—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000118	0.000192	CcSEcCtD
Rivastigmine—Fatigue—Doxorubicin—uterine cancer	0.000118	0.000192	CcSEcCtD
Rivastigmine—Urticaria—Epirubicin—uterine cancer	0.000118	0.000191	CcSEcCtD
Rivastigmine—Constipation—Doxorubicin—uterine cancer	0.000117	0.00019	CcSEcCtD
Rivastigmine—Pain—Doxorubicin—uterine cancer	0.000117	0.00019	CcSEcCtD
Rivastigmine—Abdominal pain—Epirubicin—uterine cancer	0.000117	0.00019	CcSEcCtD
Rivastigmine—Body temperature increased—Epirubicin—uterine cancer	0.000117	0.00019	CcSEcCtD
Rivastigmine—Feeling abnormal—Doxorubicin—uterine cancer	0.000113	0.000183	CcSEcCtD
Rivastigmine—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000112	0.000182	CcSEcCtD
Rivastigmine—Hypersensitivity—Epirubicin—uterine cancer	0.000109	0.000177	CcSEcCtD
Rivastigmine—Urticaria—Doxorubicin—uterine cancer	0.000109	0.000177	CcSEcCtD
Rivastigmine—Body temperature increased—Doxorubicin—uterine cancer	0.000108	0.000176	CcSEcCtD
Rivastigmine—Abdominal pain—Doxorubicin—uterine cancer	0.000108	0.000176	CcSEcCtD
Rivastigmine—Asthenia—Epirubicin—uterine cancer	0.000106	0.000173	CcSEcCtD
Rivastigmine—Pruritus—Epirubicin—uterine cancer	0.000105	0.00017	CcSEcCtD
Rivastigmine—Diarrhoea—Epirubicin—uterine cancer	0.000101	0.000165	CcSEcCtD
Rivastigmine—Hypersensitivity—Doxorubicin—uterine cancer	0.000101	0.000164	CcSEcCtD
Rivastigmine—Asthenia—Doxorubicin—uterine cancer	9.83e-05	0.00016	CcSEcCtD
Rivastigmine—Dizziness—Epirubicin—uterine cancer	9.79e-05	0.000159	CcSEcCtD
Rivastigmine—Pruritus—Doxorubicin—uterine cancer	9.69e-05	0.000157	CcSEcCtD
Rivastigmine—Vomiting—Epirubicin—uterine cancer	9.41e-05	0.000153	CcSEcCtD
Rivastigmine—Diarrhoea—Doxorubicin—uterine cancer	9.37e-05	0.000152	CcSEcCtD
Rivastigmine—Rash—Epirubicin—uterine cancer	9.33e-05	0.000152	CcSEcCtD
Rivastigmine—Dermatitis—Epirubicin—uterine cancer	9.32e-05	0.000151	CcSEcCtD
Rivastigmine—Headache—Epirubicin—uterine cancer	9.27e-05	0.000151	CcSEcCtD
Rivastigmine—Dizziness—Doxorubicin—uterine cancer	9.06e-05	0.000147	CcSEcCtD
Rivastigmine—Nausea—Epirubicin—uterine cancer	8.79e-05	0.000143	CcSEcCtD
Rivastigmine—Vomiting—Doxorubicin—uterine cancer	8.71e-05	0.000141	CcSEcCtD
Rivastigmine—Rash—Doxorubicin—uterine cancer	8.64e-05	0.00014	CcSEcCtD
Rivastigmine—Dermatitis—Doxorubicin—uterine cancer	8.63e-05	0.00014	CcSEcCtD
Rivastigmine—Headache—Doxorubicin—uterine cancer	8.58e-05	0.000139	CcSEcCtD
Rivastigmine—Nausea—Doxorubicin—uterine cancer	8.14e-05	0.000132	CcSEcCtD
